Karen L Syrjala1,2, Casey A Walsh3,4, Jean C Yi3, Wendy M Leisenring3,5, Emily Jo Rajotte3, Jenna Voutsinas3, Patricia A Ganz6, Linda A Jacobs7, Steven C Palmer7, Ann Partridge8, K Scott Baker3,5. 1. Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, D5-22098109, USA. ksyrjala@fredhutch.org. 2. University of Washington School of Medicine, Seattle, WA, USA. ksyrjala@fredhutch.org. 3. Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, D5-22098109, USA. 4. Department of Health Services, University of Washington School of Public Health, Seattle, WA, USA. 5. University of Washington School of Medicine, Seattle, WA, USA. 6. UCLA Jonsson Comprehensive Cancer Center and UCLA Fielding School of Public Health, Los Angeles, CA, USA. 7. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. 8. Dana-Farber Cancer Institute, Boston, MA, USA.
Abstract
PURPOSE: Young adult (YA) cancer survivors have high rates of adverse health and psychosocial outcomes. This risk-stratified, multicenter, randomized controlled trial (RCT) compared a self-management survivorship intervention to usual care in YA survivors with symptoms of cancer-related distress, insomnia, fatigue, pain, and/or depression. METHODS: Eligibility included age 18-39 at diagnosis with an invasive malignancy in the previous 1-5 years. Baseline assessment determined "high need" participants, with 2-5 elevated targeted symptoms. We randomized high need participants to intervention or usual care and offered intervention participants a survivorship clinic visit, which included mutually decided action plans for symptoms. Follow-up calls at 1 and 3 months after the clinic visit reviewed action plan progress. Outcomes compared rates of improved symptoms for intervention vs usual care at 6 months and 12 months. RESULTS: N = 344 completed baseline assessment, with n = 147 (43%) categorized as high need and randomized. Of n = 73 randomized to the intervention, n = 42 (58%) did not attend their survivorship clinic visit. In intent-to-treat analyses, aggregate symptom scores did not differ between arms, though distress improved for 46% in the intervention arm at 6 months compared to 18% in usual care (p = 0.03) among those with elevated distress at baseline. CONCLUSIONS: Distress improved for YAs who received self-management survivorship care. However, the study demonstrates a need for alternative strategies for providing YA survivorship care. TRIAL REGISTRATION: NCT02192333 IMPLICATIONS FOR CANCER SURVIVORS: While YA survivors demonstrate some improved distress when provided survivorship care, to make care accessible and effective, they require options such as remote delivery of care.
PURPOSE: Young adult (YA) cancer survivors have high rates of adverse health and psychosocial outcomes. This risk-stratified, multicenter, randomized controlled trial (RCT) compared a self-management survivorship intervention to usual care in YA survivors with symptoms of cancer-related distress, insomnia, fatigue, pain, and/or depression. METHODS: Eligibility included age 18-39 at diagnosis with an invasive malignancy in the previous 1-5 years. Baseline assessment determined "high need" participants, with 2-5 elevated targeted symptoms. We randomized high need participants to intervention or usual care and offered intervention participants a survivorship clinic visit, which included mutually decided action plans for symptoms. Follow-up calls at 1 and 3 months after the clinic visit reviewed action plan progress. Outcomes compared rates of improved symptoms for intervention vs usual care at 6 months and 12 months. RESULTS: N = 344 completed baseline assessment, with n = 147 (43%) categorized as high need and randomized. Of n = 73 randomized to the intervention, n = 42 (58%) did not attend their survivorship clinic visit. In intent-to-treat analyses, aggregate symptom scores did not differ between arms, though distress improved for 46% in the intervention arm at 6 months compared to 18% in usual care (p = 0.03) among those with elevated distress at baseline. CONCLUSIONS: Distress improved for YAs who received self-management survivorship care. However, the study demonstrates a need for alternative strategies for providing YA survivorship care. TRIAL REGISTRATION: NCT02192333 IMPLICATIONS FOR CANCER SURVIVORS: While YA survivors demonstrate some improved distress when provided survivorship care, to make care accessible and effective, they require options such as remote delivery of care.
Authors: James V Tricoli; Nita L Seibel; Donald G Blair; Karen Albritton; Brandon Hayes-Lattin Journal: J Natl Cancer Inst Date: 2011-03-24 Impact factor: 13.506
Authors: Archie Bleyer; Ronald Barr; Brandon Hayes-Lattin; David Thomas; Chad Ellis; Barry Anderson Journal: Nat Rev Cancer Date: 2008-04 Impact factor: 60.716
Authors: Ronald D Barr; Lynn A G Ries; Denise R Lewis; Linda C Harlan; Theresa H M Keegan; Bradley H Pollock; W Archie Bleyer Journal: Cancer Date: 2016-02-05 Impact factor: 6.860
Authors: Ashley Wilder Smith; Nita L Seibel; Denise R Lewis; Karen H Albritton; Donald F Blair; Charles D Blanke; W Archie Bleyer; David R Freyer; Ann M Geiger; Brandon Hayes-Lattin; James V Tricoli; Lynne I Wagner; Bradley J Zebrack Journal: Cancer Date: 2016-02-05 Impact factor: 6.860
Authors: Alyssa R Scott; Kelsey C Stoltzfus; Leila T Tchelebi; Daniel M Trifiletti; Eric J Lehrer; Pooja Rao; Archie Bleyer; Nicholas G Zaorsky Journal: JAMA Netw Open Date: 2020-12-01
Authors: Seth J Rotz; Jean C Yi; Betty K Hamilton; Wei Wei; Jaime M Preussler; Jan Cerny; Abhinav Deol; Heather Jim; Nandita Khera; Theresa Hahn; Shahrukh K Hashmi; Shernan Holtan; Samantha M Jaglowski; Alison W Loren; Joseph McGuirk; Jana Reynolds; Wael Saber; Bipin N Savani; Patrick Stiff; Joseph Uberti; John R Wingard; William A Wood; K Scott Baker; Navneet S Majhail; Karen L Syrjala Journal: Transplant Cell Ther Date: 2022-07-22